Tirzepatide operates as a dual agonist for GLP-1 and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors, meaning it mimics and enhances a naturally occurring mechanism in our body
"Principally, it [GLP-1] minimizes intrusive thoughts about food, urgency to respond to cravings and more mindfulness around choices based on how youll feel." "GLP-1 receptors in the brain work in part to increase the feeling of satiety, and the GLP-1 receptors in the stomach slow down gastric emptying, which increases fullness," explains Nadler
The trial used a flexible dosing protocol, permitting investigators to adjust doses based on individual tolerability and clinical judgement
Its worth repeating that these numbers come from different trials with different populations and durations, not one controlled comparison, and retatrutide is not yet an approved medication so strongest currently applies only to trial data, not to an available treatment option
doi: 10.1186/s12885-020-06766-9 7 CamposFG
Most patients experience primary amenorrhea, but some may have spontaneous menarche at a much older age (around 20 years), followed by secondary amenorrhea or irregular periods (203, 204)
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
